Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmalyte vs Normal Saline in Acute Pancreatitis
NCT04688645Phase 4Unknown
- Sponsor
- Clinical Hospital Center Rijeka
- Start
- May 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of plasmalyte in acute pancreatitis (AP) (2 arms), sponsored by Clinical Hospital Center Rijeka. Primary endpoint: New Onset Systemic inflammatory response syndrome at 30 days. Status: unknown.
02
Drugs
plasmalyte
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT04688645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688645.